Studies have shown that changes in the composition of the gut microbiota and related metabolites, such as short-chain fatty acids (SCFAs), and the release of cytokines, such as TNF-α, can modulate migraine-like pain in animal models (37). This evidence concerns the gene TNF and migraine disorder.